Skip to content

Clinical trials

Phase 2 Adenocarcinoma trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Phase: Phase 2 Country / region: Germany Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20082
20092
20101
20113
20121
20142
20152
20161
20202
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated4
Active, not recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AIO-Studien-gGmbH2
Novartis Pharmaceuticals2
PD Dr Markus Möhler2
AstraZeneca1
Carmen Schade-Brittinger1
Clovis Oncology, Inc.1
EMD Serono Research & Development Institute, Inc.1
Elevation Oncology1
European Organisation for Research and Treatment of Cancer - EORTC1
Genentech, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma20
Stomach Neoplasms4
Carcinoma3
Neoplasms3
Carcinoma, Non-Small-Cell Lung2
Carcinoma, Renal Cell2
Esophageal Neoplasms2
Neoplasm Metastasis2
Pancreatic Neoplasms2
Bulbo-Spinal Atrophy, X-Linked1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.